表紙
市場調查報告書
商品編碼
1079561

全球單克隆抗體市場(2022-2028 年):市場預測(按類型、應用、最終用戶)、區域前景、增長潛力、市場份額

Monoclonal Antibodies Market Size By Type, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介
由於癌症、傳染病、慢性和罕見病的全球發病率上升,預計到 2028 年,單克隆抗體市場將增長。

按類型劃分,除全人源化抗體、人源化抗體和嵌合抗體外,其他領域預計到 2021 年將達到約 105 億美元,並在 2028 年之前高速增長。這被認為是由於先進技術的引入、不斷的研發活動以及人工抗體的開發。

本報告探索全球單克隆抗體市場,定義和概述市場,分析新型冠狀病毒感染(COVID-19)等市場影響因素、監管環境和市場規模變化。預測、按地區細分/地區/主要國家、競爭環境、主要公司概況等匯總。

目錄

第一章調查方法

第2章執行摘要

第三章單克隆抗體產業的思考

  • 行業分類
  • 產業情況
  • 行業影響因素
    • 生長因子
    • 潛在風險和挑戰
  • 增長潛力分析
  • 監管狀態
  • 基於單克隆抗體的療法:未來趨勢
  • 波特分析
  • 競爭形勢
  • PESTEL 分析

第 4 章單克隆抗體市場:按類型

  • 主要趨勢
  • 完全人源抗體
  • 人源化抗體
  • 嵌合抗體
  • 其他

第 5 章單克隆抗體市場:按應用分類

  • 主要趨勢
  • 腫瘤
  • 自身免疫性疾病
  • 傳染病
  • 其他

第 6 章單克隆抗體市場:按最終用戶分類

  • 主要趨勢
  • 醫院
  • 專科中心
  • 其他

第 7 章單克隆抗體市場:按地區劃分

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 8 章公司簡介

  • 競爭性儀表板
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Amgen
  • Bristol Myers Squibb
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Regeneron Pharmaceuticals Inc.
  • Novartis AG
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
目錄
Product Code: 5065

The monoclonal antibodies market would expand at a progressive CAGR through 2028 owing to the rising incidence of infectious, chronic, and rare diseases, including cancer, across the globe. As per the WHO, cancer is one of the leading causes of deaths worldwide, having contributed to more than 10 million deaths in 2020 alone.

Recently, monoclonal antibodies were considered to be the most promising treatment for mild to moderate COVID-19. Imperative to note that the U.S. Food and Drug Administration authorized different monoclonal antibodies to treat COVID-19 pandemic in 2020.

The overall monoclonal antibodies industry landscape is segmented into types, application, end-use, and regional landscape.

In terms of type, the monoclonal antibodies market is divided into fully human, humanized, chimeric, and others. Out of these, the others segment is projected to grow at an appreciable pace through 2028. The market value for the segment stood at around $10.5 billion in 2021. This can be attributed to the introduction to advanced technologies, constant research and development activities to innovate newer technologies, and development of artificial antibodies.

Based on the application spectrum, the industry is divided into oncology, autoimmune diseases, infectious diseases, and others. As per industry analysis, the others segment would grow at a CAGR of 13.3% over the forecast period owing to an increasing number of development activities to detect potential therapeutic applications. In addition, a robust product pipeline to present advanced therapies for areas like migraine and transplant rejection would as well contribute to the market expansion.

With respect to end-use, the monoclonal antibodies market from the hospitals segment accounted for a business share of 40% in 2021. The segment is projected to expand at a notable rate owing to the ongoing expansion of hospital settings, extensive marketing efforts by companies to educate experts about newly introduced therapies, and increasing awareness regarding advanced treatment among professionals.

From a regional perspective, the LATAM monoclonal antibodies industry is projected to witness substantial gains through the analysis timeframe. The regional growth is being propelled by the mounting accessibility of monoclonal antibodies therapeutics, and robust presence of leading industry players in the continent.

Additionally, a rising number of product approvals in developing economies across the region, including Brazil, would augment market growth. Overall, the LATAM monoclonal antibodies market size to expected to grow at a CAGR of 13.1% through the analysis timeline.

Meanwhile, MEA monoclonal antibodies market size is expected to expand profusely in the coming years. This expansion can be accounted to the growing prevalence of infectious and rare diseases in the region, and the subsequent rise in investments towards the healthcare infrastructure, especially in countries such as United Arab Emirates, and Saudi Arabia. A latest study estimated that there are nearly 25 million people suffering from a rare disease in the Middle East.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Monoclonal antibodies industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Monoclonal Antibodies Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of chronic and infectious diseases worldwide
      • 3.3.1.2 Growing research and development activities
      • 3.3.1.3 High rate of adoption and approval in the U.S. and Europe
      • 3.3.1.4 Booming biologics market
      • 3.3.1.5 Rising applications of monoclonal antibodies
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of some monoclonal antibody therapeutics
      • 3.3.2.2 Stringent regulatory framework
  • 3.4 Growth potential analysis
    • 3.4.1 By type
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 Regulatory landscape
  • 3.6 Future trends in monoclonal antibody-based therapeutics
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
    • 3.8.2 Brand analysis
  • 3.9 PESTEL analysis

Chapter 4 Monoclonal Antibodies Market, By Type

  • 4.1 Key segment trends
  • 4.2 Fully human
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Humanized
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.4 Chimeric
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.5 Others
    • 4.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Monoclonal Antibodies Market, By Application

  • 5.1 Key segment trends
  • 5.2 Oncology
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Autoimmune diseases
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Infectious diseases
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Monoclonal Antibodies Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Specialty centers
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Monoclonal Antibodies Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.2.2 Market size, by type, 2017 - 2028 (USD Mn)
    • 7.2.3 Market size, by application, 2017 - 2028 (USD Mn)
    • 7.2.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.2.5.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.2.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.2.6.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.2.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.3.2 Market size, by type, 2017 - 2028 (USD Mn)
    • 7.3.3 Market size, by application, 2017 - 2028 (USD Mn)
    • 7.3.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.3.5.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.3.6.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.3.7 France
      • 7.3.7.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.3.7.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.7.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.3.8.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.8.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.3.9.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.9.3 Market size, by end-use, 2017 - 2028 (USD Mn)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.4.2 Market size, by type, 2017 - 2028 (USD Mn)
    • 7.4.3 Market size, by application, 2017 - 2028 (USD Mn)
    • 7.4.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.4.5 China
      • 7.4.5.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.4.5.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.4.6.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.4.7 India
      • 7.4.7.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.4.7.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.7.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.4.8.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.8.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.4.9 Singapore
      • 7.4.9.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.4.9.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.9.3 Market size, by end-use, 2017 - 2028 (USD Mn)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.5.2 Market size, by type, 2017 - 2028 (USD Mn)
    • 7.5.3 Market size, by application, 2017 - 2028 (USD Mn)
    • 7.5.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.5.5.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.5.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.5.6.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.5.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.5.7.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.5.7.3 Market size, by end-use, 2017 - 2028 (USD Mn)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.6.2 Market size, by type, 2017 - 2028 (USD Mn)
    • 7.6.3 Market size, by application, 2017 - 2028 (USD Mn)
    • 7.6.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.6.5.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.5.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.6.6.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.6.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.6.7.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.7.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.6.8 Egypt
      • 7.6.8.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.6.8.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.8.3 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.6.9 Kuwait
      • 7.6.9.1 Market size, by type, 2017 - 2028 (USD Mn)
      • 7.6.9.2 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.9.3 Market size, by end-use, 2017 - 2028 (USD Mn)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 AbbVie Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Amgen
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Bristol Myers Squibb
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Johnson & Johnson
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Merck & Co., Inc.
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Regeneron Pharmaceuticals Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Novartis AG
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 AstraZeneca
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Eli Lilly and Company
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 GlaxoSmithKline plc
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Takeda Pharmaceutical Company Limited
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis

Data Tables

  • TABLE 1. Monoclonal antibodies market, 2017 - 2021 (USD Million)
  • TABLE 2. Monoclonal antibodies market, 2022 - 2028(USD Million)
  • TABLE 3. Monoclonal antibodies market, by type, 2017 - 2021 (USD Million)
  • TABLE 4. Monoclonal antibodies market, by type, 2022 - 2028 (USD Million)
  • TABLE 5. Monoclonal antibodies market, by application, 2017 - 2021 (USD Million)
  • TABLE 6. Monoclonal antibodies market, by application, 2022 - 2028(USD Million)
  • TABLE 7. Monoclonal antibodies market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 8. Monoclonal antibodies market, by end-use, 2022 - 2028(USD Million)
  • TABLE 9. Monoclonal antibodies market, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Monoclonal antibodies market, by region, 2022 - 2028(USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Fully human market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Fully human market size, by region, 2022 - 2028(USD Million)
  • TABLE 14. Humanized market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Humanized market size, by region, 2022 - 2028(USD Million)
  • TABLE 16. Chimeric market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Chimeric market size, by region, 2022 - 2028(USD Million)
  • TABLE 18. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Others market size, by region, 2022 - 2028(USD Million)
  • TABLE 20. Oncology market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Oncology market size, by region, 2022 - 2028(USD Million)
  • TABLE 22. Autoimmune diseases market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Autoimmune diseases market size, by region, 2022 - 2028(USD Million)
  • TABLE 24. Infectious diseases market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Infectious diseases market size, by region, 2022 - 2028(USD Million)
  • TABLE 26. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Others market size, by region, 2022 - 2028(USD Million)
  • TABLE 28. Hospitals market size, by region, 2017 - 2021 (USD Million)
  • TABLE 29. Hospitals market size, by region, 2022 - 2028(USD Million)
  • TABLE 30. Specialty centers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 31. Specialty centers market size, by region, 2022 - 2028(USD Million)
  • TABLE 32. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 33. Others market size, by region, 2022 - 2028(USD Million)
  • TABLE 34. North America monoclonal antibodies market size, by country, 2017 - 2021 (USD Million)
  • TABLE 35. North America monoclonal antibodies market size, by country, 2022 - 2028 (USD Million)
  • TABLE 36. North America monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 37. North America monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 38. North America monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 39. North America monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 40. North America monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 41. North America monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 42. U.S. monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 43. U.S. monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 44. U.S. monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 45. U.S. monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 46. U.S. monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 47. U.S. monoclonal antibodies market size, by End-use, 2022 - 2028 (USD Million)
  • TABLE 48. Canada monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 49. Canada monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 50. Canada monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 51. Canada monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 52. Canada monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 53. Canada monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 54. Europe monoclonal antibodies market size, by country, 2017 - 2021 (USD Million)
  • TABLE 55. Europe monoclonal antibodies market size, by country, 2022 - 2028 (USD Million)
  • TABLE 56. Europe monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 57. Europe monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 58. Europe monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 59. Europe monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 60. Europe monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 61. Europe monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 62. Germany monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 63. Germany monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 64. Germany monoclonal antibodies market size, by application, type - 2020 (USD Million)
  • TABLE 65. Germany monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 66. Germany monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 67. Germany monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 68. UK monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 69. UK monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 70. UK monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 71. UK monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 72. UK monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 73. UK monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 74. France monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 75. France monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 76. France monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 77. France monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 78. France monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 79. France monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 80. Italy monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 81. Italy monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 82. Italy monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 83. Italy monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 84. Italy monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 85. Italy monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 86. Spain monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 87. Spain monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 88. Spain monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 89. Spain monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 90. Spain monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 91. Spain monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 92. Asia Pacific monoclonal antibodies market size, by country, 2017 - 2021 (USD Million)
  • TABLE 93. Asia Pacific monoclonal antibodies market size, by country, 2022 - 2028 (USD Million)
  • TABLE 94. Asia Pacific monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 95. Asia Pacific monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 96. Asia Pacific monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 97. Asia Pacific monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 98. Asia Pacific monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 99. Asia Pacific monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 100. Japan monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 101. Japan monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 102. Japan monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 103. Japan monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 104. Japan monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 105. Japan monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 106. China monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 107. China monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 108. China monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 109. China monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 110. China monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 111. China monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 112. India monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 113. India monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 114. India monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 115. India monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 116. India monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 117. India monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 118. Australia monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 119. Australia monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 120. Australia monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 121. Australia monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 122. Australia monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 123. Australia monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 124. Singapore monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 125. Singapore monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 126. Singapore monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 127. Singapore monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 128. Singapore monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 129. Singapore monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 130. Latin America monoclonal antibodies market size, by country, 2017 - 2021 (USD Million)
  • TABLE 131. Latin America monoclonal antibodies market size, by country, 2022 - 2028 (USD Million)
  • TABLE 132. Latin America monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 133. Latin America monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 134. Latin America monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 135. Latin America monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 136. Latin America monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 137. Latin America monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 138. Brazil monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 139. Brazil monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 140. Brazil monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 141. Brazil monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 142. Brazil monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 143. Brazil monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 144. Mexico monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 145. Mexico monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 146. Mexico monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 147. Mexico monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 148. Mexico monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 149. Mexico monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 150. Argentina monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 151. Argentina monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 152. Argentina monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 153. Argentina monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 154. Argentina monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 155. Argentina monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 156. MEA monoclonal antibodies market size, by country, 2017 - 2021 (USD Million)
  • TABLE 157. MEA monoclonal antibodies market size, by country, 2022 - 2028 (USD Million)
  • TABLE 158. MEA monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 159. MEA monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 160. MEA monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 161. MEA monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 162. MEA monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 163. MEA monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 164. South Africa monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 165. South Africa monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 166. South Africa monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 167. South Africa monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 168. South Africa monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 169. South Africa monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 170. Saudi Arabia monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 171. Saudi Arabia monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 172. Saudi Arabia monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 173. Saudi Arabia monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 174. Saudi Arabia monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 175. Saudi Arabia monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 176. UAE monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 177. UAE monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 178. UAE monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 179. UAE monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 180. UAE monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 181. UAE monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 182. Egypt monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 183. Egypt monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 184. Egypt monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 185. Egypt monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 186. Egypt monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 187. Egypt monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 188. Kuwait monoclonal antibodies market size, by type, 2017 - 2021 (USD Million)
  • TABLE 189. Kuwait monoclonal antibodies market size, by type, 2022 - 2028 (USD Million)
  • TABLE 190. Kuwait monoclonal antibodies market size, by application, 2017 - 2021 (USD Million)
  • TABLE 191. Kuwait monoclonal antibodies market size, by application, 2022 - 2028 (USD Million)
  • TABLE 192. Kuwait monoclonal antibodies market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 193. Kuwait monoclonal antibodies market size, by end-use, 2022 - 2028 (USD Million)

Charts & Figures

  • FIG. 1 Monoclonal antibodies industry 360 degree synopsis
  • FIG. 2 Industry segmentation
  • FIG. 3 Global monoclonal antibodies market, 2017 - 2028 (USD Million)
  • FIG. 4 Growth potential analysis, by type
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 Company matrix analysis, 2021
  • FIG. 9 Brand analysis
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by type
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by end-use
  • FIG. 14 Key regional trends
  • FIG. 15 Competitive dashboard, 2021